1 |
Tipton DA, Stricklin GP, and Dabbous MK. Fibroblast heterogeneity of collagenolytic response to cyclosporine. J Cell Biochem 1991:46: 152-165
DOI
PUBMED
|
2 |
Coley C. Jarvis K and Hassell T. Effect of cyclosporine-A on human gingival fibroblasts in vitro. J Dent Res 1986; 65:353
|
3 |
Williamson MS. Miller EK. Plemens J. Rees T and Iacopino AM. Cyclosporine-A upregulates interleukin-f gene expression in human gingiva: possible mechanism for gingival overgrowth. J Periodontol 1994;65(10) :895-903
DOI
PUBMED
ScienceOn
|
4 |
Hyland PL. McKeown ST. Mackenzie IC and Irwin CR. Regulation of keratinocyte growth factor and scatter factor in cyclosporin-induced gingival overgrowth. J Oral Pathol Med 2004;33(7) :391-397
DOI
ScienceOn
|
5 |
Iacopino AM. Doxey D and Cutler CW. Phenytoin and cyclosporine A specifically regulate macrophage and expression of platelet derived growth factor and interleukinl in vitro and in vivo: possible mechanism of drug induced overgrowth. J Periodontol 1997; 68: 73-83
DOI
PUBMED
ScienceOn
|
6 |
Chen DF, Schneider GE. Martinou JC and Tonegawa S. Bcl-2 promotes regeneration of severed axons in mammalian CNS. Nature 1997:385(6615): 391-393
DOI
PUBMED
ScienceOn
|
7 |
Crompton M. Mitochondrial intermembrane junctional complexes and their role in cell death. J Physiol 2000; 529 : 11-21
DOI
ScienceOn
|
8 |
Adams JM and Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998; 281: 1322-1326
DOI
PUBMED
ScienceOn
|
9 |
Tsujimoto Y and Shimizu S. Bcl-2: Life-or-death switch. FEBS Lett 2000;466: 6-10
DOI
ScienceOn
|
10 |
Beer R Frenz G. Schopf M. Reindl M. Zelger B. Schmutzhard E. Poewe W and Kampfl A. Expression of Fas and Fas ligand after experimental traumatic brain injury in the rat. J Cereb Blood Flow Metab. 2000:20: 669-677
|
11 |
Nor JE, Christensen J, Liu J, Peters M, Mooney DJ, Strieter RM. Polverini PJ. Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth. Cancer Res 2001:61(5) :2183-2188
PUBMED
|
12 |
Bonnefoy-Berard N, Aouacheria A, Verschelde C, Quemeneur L, Marcais A and Marvel J. Control of proliferation by Bcl-2 family members. Biochem Biophys Acta 2004:1644(2-3):159-168
DOI
ScienceOn
|
13 |
Furukawa Y, Iwase S, Kikuchi J, Terui Y, Nakamura M. Yamada H, Kano Y and Matsuda M. Phosphorylation of Bcl-2 protein by CDC2 kinase during G2/M phases and its role in cell cycle regulation J Biol Chem 2000: 275(28): 21661-21667
DOI
ScienceOn
|
14 |
Li P. Nijhawan D. Budihardjo I. Srinivasula SM. Ahmad M. Alnemri ES and Wand X. Cytochrome c and dATP-dependent formation of Aparf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997: 91 : 479-489
DOI
ScienceOn
|
15 |
Araya R. Uehara T and Nomura Y. Hypoxia induces apoptosis in human neuroblastoma SK-N-MC cells by caspase activation accompanying cytochrome c release from mitochondria. FEBS Lett 1998:439:168-172
DOI
PUBMED
ScienceOn
|
16 |
Zamzami N and Kroemer G. The mitochondrion in apoptosis how Pandora's box opens. Nat Rev Mol Cell Biol 2001:2:67-71
DOI
ScienceOn
|
17 |
Roth JA, Feng L. Walowitz J and Browne RW. Manganese -induced rat pheochromocytoma cell death is independent of caspase activation. J Neurosci Res 2000;61:162-171
DOI
ScienceOn
|
18 |
Schincaglia GP. Forniti F. Cavallini R. Piva R. Calura G and del Senno L. Cyclosporin-A increases type I procollagen production and mRNA level in human gingival fibroblasts in vitro. J Oral Pathol Med 1992;21(4):181-185
DOI
ScienceOn
|
19 |
Thornberry NA, Rano TA. Peterson EP, Rasper DM. Timkey T. Garcia-Calve M, Houtzager VM. Nordstrom PA. Roy S. Vaillancourt JP. Chapman KT and Nicholson DW. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J Biol Chem 1997:272:17907-17911
DOI
ScienceOn
|
20 |
Cotrim P. Martelli-Junior H. Graner E. Sauk JJ and Coletta RD. Cyclosporin A induces proliferation in human gingival fibroblasts via induction of transforming growth factor-beta 1. J Periodontol 2003; 74(11): 1625-1633
DOI
ScienceOn
|
21 |
Takahashi T and Kamimura A. Cyclesporin a promotes hair epithelial cell proliferation and modulates protein kinase C expression and translocation in hair epithelial cells. J Invest Dermatol 2001:117(3):605-611
DOI
ScienceOn
|
22 |
Deng X, Gao F and May WS. Bcl2 retards G1/S cell cycle transition by regulating intracellular ROS. Blood 2003 : 3179-3185
PUBMED
|
23 |
Hassel T, Buchanan J, Cuchens M and Doudhlas J. Fluoresence activated vital cell sorting of human fibroblasts subpopulations that bind Cyclosporine A. J Dent Res 1988:67:273
|
24 |
Gross A, Yin XM. Wang K. Wei MC. Jockel J. Milliman C. Erdiumcnt-Bromage H, Tempst P and Korsmeyer SJ Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death. J Biol Chem 1999:274: 1156-1163
DOI
ScienceOn
|
25 |
Petronilli V, Nicolli A Costantini P, Colonna R. and Bernardi P. Regulation of the permeability transition pore, a voltage-dependent mitochondrial channel inhibited by cyclosporin A. Biochim Biophys Acta 1994:1187:255-259
DOI
ScienceOn
|
26 |
Phipps RP. Borrello MA and Blieden TM. Fibroblast heterogeneity in the periodontium and other tissues. J Periodontal Res 1997:32(1-2):159-165
DOI
ScienceOn
|
27 |
Wang K. Yin XM. Chao DT. Milliman CL and Korsmeyer SJ. BID: a novel BH3 domain-only death agonist. Genes Dev 1996:10:2859-2869
DOI
ScienceOn
|
28 |
Faulds D, Goa KL and Benfield P, Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders, Drugs 1993:45(6): 953-1040
DOI
ScienceOn
|
29 |
Mascarell L. Auger R, Alcover A. Ojcius DM. Jungas T. Cadet-Daniel V. Kanellopoulos JM and Truffa-Bachi P. Characterization of a gene encoding two isoforms of a mitochondrial protein upregulated by cyclosporin A in activated T cells. J Biol Chem 2004;279(11): 10556 -10563
DOI
ScienceOn
|
30 |
Limana F, Urbanek K, Chimenti S, Quaini F, Leri A Kajstura J, NadalGinard B, Izumo Sand Anversa P. bcl-2 overexpression promotes myocyte proliferation. Proc Natl Acad Sci USA 2002: 99(9):6257-6262
DOI
ScienceOn
|
31 |
Martinou JC and Green DR. Breaking the mitochondrial barrier. Nat Rev Mol Cell Biol 2001: 2: 63-67
DOI
ScienceOn
|
32 |
Daley TF, Wysocki GP and Day C, Clinical and pharmacological correlations in cyclosporine induced gingival hyperplasia, Oral Surg, Oral Med, Oral Pathol 1986:62:417-421
DOI
ScienceOn
|
33 |
Jacobs D and Hassel TM. The effect of cyclosporin metabolite OL-17 on gingival fibroblast sub populations, J Dent Res 1990: 69: 221
|
34 |
Wysocki GP, Gretzinger HA, Laupacis A, Ulan RA and Stiller CR. Fibrous hyperplasia of the gingiva, A side effect of cyclosporin A therapy. Oral Surg, Oral Med, Oral Pathol 1983:55:274-278
DOI
ScienceOn
|
35 |
Zamzami N, Marchetti P, Castedo M. Hirsch T, Susin SA, Masse Band Kroemer G. Inhibitors of permeability transition interfere with the disruption of the mitochondrial transmembrane potential during apoptosis. FEBS Lett 1996:384:53-57
DOI
ScienceOn
|
36 |
Paul LC, Overview of side effects of immunosuppressive therapy, Transplant Proc 2001:33:2089-2091
DOI
PUBMED
ScienceOn
|
37 |
Chabria D, Weintraub RG and Kilpatrick NM, Mechanisms and management of gingival overgrowth in paediatric transplant recipients: a review, Int J Paediatr Dent 2003:13(4):220-229
DOI
ScienceOn
|
38 |
Scatena CD, Stewart ZA, Mays D, Tang LJ, Keefer CJ, Leach SD and Pietenpol JA. Mitotic phosphorylation of Bcl-2 during normal cell cycle progression and Taxol-induced growth arrest. J Biol Chem 1998:273:30777-30784
DOI
|